TechniScan enters phase 2 of cooperation with University of California using WBU, Women's Imaging

E-mail Print PDF


Women's Imaging: TechniScan, a medical device company developing automated breast ultrasound imaging system, mentioned that it has techniscan-logostarted phase two of its large study at the University of California, San Diego (UCSD) Moores Cancer Center. TechniScan's Warm Bath Ultrasound  (WBU) system is developed to capture 3D images of the breast as patient lies prone on a table and the ultrasound system technology is applied in a warm water tank to generate images of the breast structures.

The Moores UCSD Cancer Center is a National Cancer Institute (NCI) having scientists and clinicians aiming on developing next generation of cancer therapies and medications. The TechniScan Warm Bath Ultrasound system applications and researches will be carried out by Michael P. Andre, Ph.D., Professor of Radiology, and breast radiologists Dr. Linda Olson and Dr. Haydee Ojeda-Fournier. While the funds are provided by NCI Small Business Innovation Research Grant (SBIR) from the National Institute of Health, the study will include about 130 women having different types of breast lesions.  The main objectives of the 12 month study will be the comparison between WBU and conventional breast ultrasound systems. Another objective is to assess the WBU system's ability for identification between normal, benign and malignant breast structures.

Professor Andre said "We are excited to begin this new phase in the development of WBU; it marks a genuine milestone in which our work may be translated to the front lines of the clinical world,". Researchers participating in the study will also use TechniScan's imaging network. The network offers them the ability to archive, store, and review WBU images along with medical records and to cooperate with other researchers at sites in Freiburg, Germany, Salt Lake City and Rochester, Minnesota.

"Our vision is to begin to create a database of thousands of breast images and related data," said Dave Robinson, chief executive officer at TechniScan, Inc. Robinson added "With complete anonymity, women may contribute their mammograms, breast MRI's and WBU images, along with related pathology and other information, to provide researchers around the world an unprecedented opportunity to study breast cancer. TechniScan's imaging network will also allow timely and efficient collaboration of patient's records for her medical team's use. The concept is simple, yet revolutionary within the medical system and represents a key competitive advantage of the TechniScan system."

These signals are relayed buying clomid online safe which then is by a number of such as medial preoptic and paraventricular nulcei.